← Leaderboards
Robert J Haselbeck
Elitra Pharmaceuticals, Inc.
$3,943,980
Attributed
$3,943,980
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–07$2M$1.5M$1M$500K$0
'05
'06
'07
Funding mix
By agency
NIH$3,943,980 · 6
By mechanism
R44$3,741,082 · 3
R43$200,898 · 2
R03$2,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Elitra Pharmaceuticals, Inc.
Same institution · by research overlap
- John D. Trawick$1,076,935
Others in their field
Top investigators on “Genetic Library”
- Richard A Gibbs · Baylor College Of Medicine$429,374,581
- Robert H Waterston · Washington University$148,148,258
- Joseph E Robertson · Oregon Health & Science University$129,896,064
- Peter Gordon Gillespie · Oregon Health And Science University$111,179,735
- Richard K. Wilson · Washington University$105,791,361
- Stacey Gabriel · Massachusetts Institute Of Technology$43,488,239
Research focus
Genetic LibraryTransfection /Expression VectorAntibioticsHigh Throughput TechnologyGene ExpressionAntisense Nucleic AcidStaphylococcus AureusGenetic ScreeningMethod DevelopmentFungal GeneticsBioterrorism /Chemical WarfareLaboratory MousePolymerase Chain ReactionProtein EngineeringExpression CloningBiotechnologyDrug Discovery /IsolationComplementary DnaDrug Design /Synthesis /ProductionAspergillusBacillus AnthracisChromosome ComplementDrug Screening /EvaluationTransposon /Insertion Element
Grant awards (8)
Identification of Target-Specific Antimicrobials$2,000
R03 · FY2007 · MH · contact PI
Target and antibiotic discovery in Bacillus anthracis$753,447
R44 · FY2006 · AI · contact PI
Target and antibiotic discovery in Bacillus anthracis$1,075,096
R44 · FY2005 · AI
Target and antibiotic discovery in Bacillus anthracis$952,905
R44 · FY2004 · AI
Essential Gene Drug Targets in Aspergillus fumigatus$449,955
R44 · FY2004 · AI
Antibodic Discovery by Gram-positive Fitness Test Assay$509,679
R44 · FY2003 · AI
Screen for essential genes in Aspergillus fumigatus$100,764
R43 · FY2001 · AI
IDENTIFICATION OF NEW ANTIBIOTIC TARGETS USING BACS$100,134
R43 · FY2000 · AI